Christopher Ryan on Muck Rack

Christopher Ryan

Sydney
As seen in: Cambridge University Press & Assessment, SAGE Publishing, The Conversation, JAMA (The Journal of the American Medical Association), Royal Society of Chemistry, SBS, Las Vegas Sun, NewsBreak, Texas Medical Center, The British Journal of Psychiatry and
Consultation-Liaison Psychiatrist
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Christopher

Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Readmissions After Surgical Aortic Valve Replacement: Influence of Prosthesis Type

|
By Christopher B Sylvester, Christopher Ryan, William C. Frankel, Rodrigo Zea-Vera
| Texas Medical Center
INTRODUCTION: Prosthesis choice during aortic valve replacement (AVR) weighs lifelong anticoagulation with mechanical valves (M-AVR) against structural valve degeneration in bioprosthetic valves (B-AVR). METHODS: The Nationwide Readmissions Database was queried to identify patients who underwent isolated surgical AVR between January 1, 2016 and December 31, 2018, stratifying by prothesis type. Propensity score matching was used to compare risk-adjusted outcomes.
Open in Who Shared Issue with article?

The zero suicide approach: style over substance

|
By Calina Ouliaris, Pramudie Gunaratne, Christopher Ryan, Sebastian Rosenberg
| Cambridge University Press & Assessment
Hostname: page-component-6bf8c574d5-n2sc8 Total loading time: 0 Render date: 2025-03-10T05:50:46.276Z Has data issue: false hasContentIssue false Published online by Cambridge University Press: 10 March 2025 Calina Ouliaris [Opens in a new window] , Pramudie Gunaratne [Opens in a new window] , Christopher Ryan [Opens in a new window] , Sebastian Rosenberg [Opens in a new window] , Luis Salvador-Carulla [Opens in a new window] and Neeraj Gill [Opens in a new window] Show author details Type...
Open in Who Shared Issue with article?

Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial

|
By Shuchi Gulati, Catherine Tangen, Christopher Ryan, Ulka Vaishampayan
| JAMA (The Journal of the American Medical Association)
Key Points Question Does adjuvant everolimus improve recurrence-free and overall survival in patients with localized non–clear cell renal cell carcinoma (RCC)? Findings This secondary analysis of a randomized clinical trial subgroup included 109 patients with papillary RCC and 99 patients with chromophobe RCC. In both groups, patients treated with adjuvant everolimus did not experience an improvement in recurrence-free survival compared with patients treated with placebo.
Open in Who Shared Issue with article?
See all 48 licensed articles (51 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Christopher

Contact Christopher, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified